Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Gardasil Slated For Advisory Committee Review May 18

This article was originally published in The Pink Sheet Daily

Executive Summary

Vaccines & Related Biological Products committee will review HPV vaccine less than a month ahead of June 8 priority review user fee date.

You may also be interested in...



Merck’s Biotech Pipeline Gets A Boost From Two Acquisitions

Merck will buy the monoclonal antibody developer Abmaxis and yeast glycoengineering specialist GlycoFi.

Merck’s Biotech Pipeline Gets A Boost From Two Acquisitions

Merck will buy the monoclonal antibody developer Abmaxis and yeast glycoengineering specialist GlycoFi.

Merck Launches HPV Awareness Campaign In Preparation For Gardasil

The firm has launched television, radio and print ads although the HPV vaccine is still pending at FDA.

Related Content

Topics

UsernamePublicRestriction

Register

PS064242

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel